Inactive Instrument
NovImmune SA Share Price
Stocks
IPO-NOVI
CH0010924170
Biotechnology & Medical Research
|
End-of-day quote
Swiss Exchange
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Nicolas Fischer
CEO | Chief Executive Officer | - | 30/06/2019 |
Nathalie Muller
ADM | Chief Administrative Officer | - | 31/12/1999 |
Hartmut Wekerle
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 81 | 31/01/2008 | |
| Director/Board Member | - | - | |
Tuygan Göker
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.41% | +0.29% | +42.02% | +71.57% | 64.69B | |
| -0.15% | +7.50% | +11.01% | +73.48% | 54.78B | |
| +0.57% | +4.60% | +10.07% | +92.86% | 53.49B | |
| +0.37% | +4.67% | +27.03% | +52.07% | 45.98B | |
| -1.21% | +2.32% | +21.80% | +123.81% | 42.94B | |
| -0.37% | +5.07% | +249.91% | +918.74% | 40.08B | |
| +0.05% | +0.21% | +18.26% | +58.53% | 33.52B | |
| -0.38% | +5.68% | +36.43% | +27.54% | 23.67B | |
| +1.19% | -4.98% | +29.01% | -0.65% | 23.97B | |
| Average | +0.28% | +2.41% | +49.51% | +157.55% | 42.57B | |
| Weighted average by Cap. | +0.39% | +2.73% | +47.57% | +158.58% |
Employees
-
- Stock Market
- Stocks
- IPO-NOVI Stock
Select your edition
All financial news and data tailored to specific country editions
